recent
emerg
new
strain
influenza
influenza
emphas
need
rapid
high
throughput
system
identifi
virus
respiratori
specimen
diagnosi
must
also
abl
differenti
influenza
respiratori
virus
may
appear
complic
influenza
infect
might
lead
hospit
intens
care
unit
number
avail
bed
limit
fuhrman
et
al
molecular
diagnosi
viral
infect
becom
gold
standard
hospit
laboratori
replac
increasingli
cellular
viru
cultur
direct
immunoassay
pcr
improv
biolog
manag
nucleic
acid
extract
step
remain
fulli
autom
extract
instrument
need
high
qualiti
pcr
assay
identifi
broad
rang
virus
perform
high
qualiti
total
nucleic
acid
extract
first
autom
system
abl
extract
nucleic
acid
variou
clinic
specimen
limit
capac
sampl
sever
high
throughput
autom
platform
avail
includ
coba
roch
diagnost
meylan
franc
et
al
schumach
et
al
sizmann
et
al
alp
hascelik
nuclisen
easymag
boxtel
netherland
loen
et
al
perandin
et
al
pillet
et
al
qiagen
qiasymphoni
sp
qiagen
valencia
ca
miller
et
al
system
abbott
laboratori
north
chicago
il
scott
et
al
system
capabl
extract
high
qualiti
viru
nucleic
acid
still
requir
hr
extract
sampl
recent
avail
magna
pure
roch
diagnost
claim
abl
extract
nucleic
acid
sampl
less
hr
aim
studi
examin
perform
magna
pure
system
conveni
routin
use
comparison
coba
first
test
sampl
seri
dilut
influenza
extract
use
magna
pure
coba
magna
pure
instrument
roch
seri
clinic
respiratori
specimen
analyz
use
magna
pure
coba
instrument
pcr
influenza
intralaboratori
qualiti
control
iqc
dilut
minimum
essenti
medium
obtain
five
dilut
iqc
prepar
infect
cultur
madin
darbi
canin
kidney
cell
clinic
respiratori
specimen
nucleic
acid
extract
dilut
duplic
use
three
extract
system
magna
pure
coba
magna
pure
total
clinic
respiratori
sampl
collect
prospect
week
januari
februari
depart
virolog
chu
toulous
franc
nucleic
acid
extract
sampl
use
coba
magna
pure
instrument
throat
sampl
collect
virolog
adapt
kitvia
labarth
inard
franc
nasopharyng
swab
sampl
collect
fluid
collect
steril
tube
sampl
test
sever
virus
includ
influenza
influenza
rhinoviru
enteroviru
adenoviru
varicella
zoster
viru
cytomegaloviru
herp
simplex
type
tabl
respiratori
clinic
sampl
test
posit
adenoviru
n
cytomegaloviru
n
enteroviru
n
hsv
n
also
test
nasopharyng
specimen
adenoviru
enteroviru
bronchoalveolar
fluid
cytomegaloviru
hsv
three
system
use
magna
pure
lc
total
nucleic
roch
magna
pure
instrument
coba
ampliprep
total
nucleic
acid
isol
tnai
roch
coba
instrument
mengel
et
al
magna
pure
dna
viral
na
small
volum
roch
magna
pure
input
output
volum
magna
system
volum
coba
pcr
test
use
describ
tabl
influenza
influenza
virus
detect
realtim
readi
inf
detect
rna
viru
accord
manufactur
instruct
light
cycler
system
roch
diagnost
set
contain
specif
primerprob
mix
detect
influenza
matrix
protein
mexico
variant
specif
hemagglutinin
singl
pass
rhinoviru
detect
light
cycler
instrument
techniqu
kare
et
al
sampl
underw
one
step
use
sybr
green
techniqu
melt
curv
analysi
use
identifi
rhinoviru
enteroviru
verstrepen
et
al
adenoviru
heim
et
al
varicella
zoster
viru
espi
et
al
cytomegaloviru
mengel
et
al
detect
light
cycler
use
pcr
herp
simplex
type
detect
light
cycler
previous
describ
mengel
et
al
fret
technolog
use
melt
curv
analysi
differenti
data
analyz
use
softwar
statacorp
colleg
station
tx
kappa
cohen
test
use
compar
perform
assay
consid
signific
five
dilut
iqc
influenza
extract
twice
three
extract
instrument
magna
pure
coba
magna
pure
extract
test
influenza
target
influenza
target
influenza
influenza
virus
detect
rna
extract
three
instrument
undilut
iqc
dilut
target
detect
dilut
extract
magna
pure
magna
pure
tabl
ii
everi
target
detect
dilut
extract
coba
instrument
target
detect
one
dilut
extract
magna
pure
instrument
target
neg
dilut
extract
magna
pure
coba
instrument
sampl
test
influenza
influenza
three
sampl
influenza
posit
wherea
neg
one
nasopharyng
sampl
posit
magna
pure
neg
coba
two
sampl
influenza
posit
neg
extract
method
one
nasopharyng
sampl
posit
magna
pure
extract
neg
coba
extract
detect
influenza
influenza
concord
p
sampl
test
rhinoviru
sampl
posit
neg
extract
system
two
sampl
magna
pure
posit
coba
neg
detect
concord
p
result
enteroviru
agre
sampl
posit
neg
techniqu
disagre
one
sampl
magna
pure
neg
tabl
iii
two
extract
system
agre
adenoviru
sampl
posit
sampl
neg
varicella
zoster
viru
six
neg
sampl
sampl
test
cytomegaloviru
neg
posit
method
one
sampl
magna
pure
posit
coba
neg
thu
concord
p
detect
gave
concord
result
sampl
gave
ident
result
sampl
posit
neg
p
posit
result
gave
ident
herp
viru
type
one
sampl
magna
pure
positivecoba
neg
one
sampl
gave
opposit
result
sampl
specimen
contain
littl
herp
simplex
type
tabl
iv
magna
pure
coba
use
technolog
lysi
releas
nucleic
acid
bound
silica
surfac
ad
magnet
particl
due
chaotrop
salt
condit
high
ionic
strength
lyse
reagent
reagent
suppli
instrument
may
kept
room
temperatur
day
howev
instrument
use
differ
sampl
dispens
step
sampl
onto
coba
extract
sampl
take
least
hr
magna
pure
instrument
use
pipett
head
sampl
process
singl
run
less
hr
magna
pure
also
requir
input
volum
elut
provid
pcr
test
requir
input
volum
least
seven
virus
detect
singl
extract
perform
new
commerci
avail
high
throughput
extract
system
evalu
compar
older
system
standard
sampl
routin
clinic
sampl
similar
result
obtain
rna
extract
dilut
influenza
three
system
magna
pure
coba
magna
pure
previou
studi
quantif
ebv
mengel
et
al
cmv
mengel
et
al
whole
blood
found
good
correl
magna
pure
system
coba
thu
data
show
import
compar
new
extract
system
magna
pure
anoth
highli
automat
instrument
use
ident
technolog
coba
purpos
total
viru
nucleic
acid
dna
rna
extract
respiratori
specimen
instrument
test
sever
virus
influenza
influenza
rhinoviru
enteroviru
adenoviru
varicella
zoster
viru
cytomegaloviru
herp
viru
type
pcr
previou
studi
shown
high
throughput
autom
extract
system
use
nasopharyng
aspir
chan
et
al
plasma
miller
et
al
edta
whole
blood
sampl
pillet
et
al
chan
et
al
compar
two
automat
extract
system
nuclisen
easymag
qiagen
biorobot
manual
qiaamp
qiagen
extract
method
found
differ
sensit
three
method
furthermor
recent
magna
pure
system
provid
platform
extract
variou
clinic
specimen
believ
first
report
use
magna
pure
instrument
extract
nucleic
acid
larg
number
routin
clinic
respiratori
specimen
includ
fluid
throat
sampl
nasopharyng
sampl
collect
week
influenza
pandem
result
show
two
extract
system
perform
similarli
clinic
respiratori
specimen
regardless
pcr
technolog
use
moreov
method
perform
similarli
regardless
structur
virus
dna
rna
without
envelop
virus
test
serv
model
virus
includ
influenza
b
respiratori
syncyti
viru
coronavirus
these
virus
varicella
zoster
viru
rare
found
respiratori
infect
prospect
studi
item
request
clinician
test
use
new
autom
system
entail
chang
sampl
prepar
sampl
dilut
mix
minimum
essenti
medium
extract
extra
medium
cystein
necessari
magna
pure
extract
sampl
less
hr
sever
extract
run
singl
day
necessari
advent
magna
pure
lead
huge
chang
organ
laboratori
two
extract
day
run
clear
daili
incom
clinic
specimen
addit
elut
volum
singl
extract
need
even
sever
pcr
test
done
greatli
reduc
technician
time
henc
cost
entir
pcr
test
pcr
assay
carri
day
wait
time
result
decreas
dramat
number
phone
call
clinician
magna
pure
softwar
use
technician
requir
long
initi
train
mainten
also
easi
requir
minut
day
conclus
magna
pure
high
throughput
autom
extract
system
reliabl
devic
extract
total
viru
nucleic
acid
broad
rang
clinic
respiratori
specimen
order
detect
virus
variou
pcr
test
batch
sampl
extract
less
hr
allow
rapid
molecular
diagnosi
thu
identif
viral
pathogen
oper
time
reduc
thank
use
reagent
kept
room
temperatur
featur
great
econom
import
addit
provid
rapid
diagnosi
improv
patient
manag
